On July 28, 2025, INVO Fertility, Inc. reported that an existing investor acquired 200 shares of Series C-2 Convertible Preferred Stock for $200,000, adjusting the conversion price to $1.8909 per share. This transaction was made without public registration, relying on private offering exemptions.